Non-muscle alpha-dystroglycan is involved in epithelial development. - Wikidata - wikimedia - TriplyDB

Non-muscle alpha-dystroglycan is involved in epithelial development.

Non-muscle alpha-dystroglycan is involved in epithelial development.

http://www.wikidata.org/entity/Q36235753

about

Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissues Agrin is a major heparan sulfate proteoglycan in the human glomerular basement membrane Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan Laminin isoforms in endothelial and perivascular basement membranes Adhesion of cultured bovine aortic endothelial cells to laminin-1 mediated by dystroglycan A role of dystroglycan in schwannoma cell adhesion to laminin Expression of agrin, dystroglycan, and utrophin in normal renal tissue and in experimental glomerulopathies Localization of cranin (dystroglycan) at sites of cell-matrix and cell-cell contact: recruitment to focal adhesions is dependent upon extracellular ligands Glycosylation defects: a new mechanism for muscular dystrophy?Dystroglycan versatility in cell adhesion: a tale of multiple motifs.Dystroglycan is involved in skin morphogenesis downstream of the Notch signaling pathway.Ligation of alpha-dystroglycan on podocytes induces intracellular signaling: a new mechanism for podocyte effacement?Embryonic renal epithelia: induction, nephrogenesis, and cell differentiation.Transgenic overexpression of LARGE induces α-dystroglycan hyperglycosylation in skeletal and cardiac muscle Dystroglycan is not required for maintenance of the luminal epithelial basement membrane or cell polarity in the mouse prostate.Fibroblast growth factor signaling and basement membrane assembly are connected during epithelial morphogenesis of the embryoid body Glycoproteomic characterization of recombinant mouse α-dystroglycan.Dystroglycan loss disrupts polarity and beta-casein induction in mammary epithelial cells by perturbing laminin anchoring.Dystroglycan does not contribute significantly to kidney development or function, in health or after injury.Flow cytometry for the analysis of α-dystroglycan glycosylation in fibroblasts from patients with dystroglycanopathies.Protein O-mannosylation: conserved from bacteria to humans.Epithelial mesenchymal interactions, the ECM and limb development.Update of extracellular matrix, its receptors, and cell adhesion molecules in mammalian nephrogenesis.An antiglycolipid antibody inhibits Madin-Darby canine kidney cell adhesion to laminin and interferes with basolateral polarization and tight junction formation.Molecular and functional defects in kidneys of mice lacking collagen alpha 3(IV): implications for Alport syndrome.Subtle neuromuscular defects in utrophin-deficient mice.A PDZ-containing scaffold related to the dystrophin complex at the basolateral membrane of epithelial cells.alpha-Dystroglycan is a laminin receptor involved in extracellular matrix assembly on myotubes and muscle cell viability.Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancer.Melanocytes--a novel tool to study mitochondrial dysfunction in Duchenne muscular dystrophy.Division of labor among the alpha6beta4 integrin, beta1 integrins, and an E3 laminin receptor to signal morphogenesis and beta-casein expression in mammary epithelial cells Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE.Adeno-associated virus 9 mediated FKRP gene therapy restores functional glycosylation of α-dystroglycan and improves muscle functions Dystroglycan receptor is involved in integrin activation in intestinal epithelia Biological role of dystroglycan in Schwann cell function and its implications in peripheral nervous system diseases.Extracellular matrix receptors in branched organs Abnormalities in alpha-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies.Nuclear targeting of dystroglycan promotes the expression of androgen regulated transcription factors in prostate cancer.The transgenic expression of LARGE exacerbates the muscle phenotype of dystroglycanopathy mice.

P2860

Q24294992-7AEDC7D8-36AE-4183-BF4F-81B2156E6E6C Q24302249-C3172AB7-A172-49EC-AF15-E939E61F1D6D Q24314924-B97E5932-C7F6-49E7-B65D-340F744B0EE1 Q24321692-849426CB-CFB9-48CD-8E69-85D12745DDF0 Q26858989-E2E916C4-8324-42DC-802B-CB9ECBB075A6 Q28141804-9A0227B8-1E2F-4A8B-8C5C-63DC10EBF194 Q28238357-572DCDC7-3F4C-41CB-A646-E9213F7AE798 Q28344242-33720BF0-9EDF-429D-A682-A0C6FBE52926 Q28564879-86A1BB8B-5DDE-4AE6-89C9-D55C733E3B4F Q28587952-05D08072-24E9-4FFA-A037-15C0FA454C40 Q30156956-CBAF11BB-7A68-4C2A-9144-7CFA3FA5A3DE Q30430129-9A7642D7-8C45-4C78-8D43-BB264609809F Q33471500-4D7A2FCE-4A8B-48AB-A780-B608152291B2 Q33744636-36F738F0-7F02-49DF-98AE-8AD0824720CD Q33784310-9E403AA5-5909-475C-9D9A-DED12377F86E Q33802362-F6888806-6685-4FF3-AB54-FA968CADC7E5 Q33946703-685F7E30-4178-46F0-A5B1-497D66B72CE1 Q34126184-A2EE9046-594E-4237-9B4D-DB62E2269DB1 Q34377781-71685835-384C-4A1D-8CBE-4EFA492E71D1 Q34719164-FFEA0425-7EC9-48CD-BAC9-96A2476B5FEB Q34873693-81D579B3-9D76-4660-889E-E44BF4FA2C33 Q34980261-67FE00B2-19DD-4306-AFA1-7D819B76301B Q35066894-67D74861-54FC-46C2-B211-DB4A4C709177 Q35620998-63474788-A17A-4058-BB8D-FA883DEC07FA Q36236789-98111FE5-A7D3-442E-84C8-A30FB07A0F13 Q36237693-12FC7A24-A312-48D1-BEA5-C679DCFBB63A Q36254585-24FFA675-A00A-49AB-A420-677BEB87FC49 Q36256456-E72BB0DD-24B0-46BD-B268-BB35ECEFD125 Q36256527-B7ECBB31-4676-4FF7-BD9D-0A60DC3758EE Q36561917-3E850FB8-EDB7-4AFF-B6D5-081E2C1371BC Q36695834-F259C92B-01D7-466E-BD2E-68A828ED9295 Q36906768-D4EB5B78-2CBC-4569-B08C-EF999A98B45B Q37160880-A6EA391B-4C53-402C-BB17-6C33F2FA4EB0 Q37254859-C413EC71-1AC7-4F57-829C-EA279F453556 Q37335465-908BAB28-B353-47E7-B45A-F9A2478B8FFC Q37772080-F8128C1C-5CD2-4C76-813E-DF22BC1FC16C Q37874363-4FD20E44-E262-4E46-804E-3DD7411528F4 Q38584853-A011EA79-5EF8-4B48-B966-633154B023E3 Q39090168-B168690B-A246-4857-9F6C-C0C407D9FA11 Q39314908-8D4C0D09-7710-42FA-BD22-1E870386A135

P2860

Non-muscle alpha-dystroglycan is involved in epithelial development.

http://www.wikidata.org/entity/Q36235753

description

1995 nî lūn-bûn

@nan

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

1995年论文

@zh

1995年论文

@zh-cn

name

Non-muscle alpha-dystroglycan is involved in epithelial development.

@ast

Non-muscle alpha-dystroglycan is involved in epithelial development.

@en

type

label

Non-muscle alpha-dystroglycan is involved in epithelial development.

@ast

Non-muscle alpha-dystroglycan is involved in epithelial development.

@en

prefLabel

Non-muscle alpha-dystroglycan is involved in epithelial development.

@ast

Non-muscle alpha-dystroglycan is involved in epithelial development.

@en

P1433

Q36235753-DB032AB3-F969-48B2-A24C-E52AF3B30258

P1476

Q36235753-5BC06AF4-C641-4059-BB67-F44BB33BA700

P2093

Q36235753-33D75CE6-D5B5-4F1C-A8EE-A077E4992659

Q36235753-3ECCDF98-C281-4D67-A7ED-21245729F63F

Q36235753-67B22593-B095-48BF-A6CF-A95CB7A3475D

Q36235753-7F285706-B605-47DA-BAB7-F98129FE40D4

Q36235753-81282548-F9C7-4F41-B736-A90A054386A5

Q36235753-BC7B547F-AC99-46F5-A5D3-473C2F256B6A

P2860

Q36235753-016EF9C8-BE38-446E-B5DF-D8BD93D151C2

Q36235753-045EC0F9-A8BB-4068-B805-103D729C151F

Q36235753-05257FBB-84BF-42E9-A7AF-F30D9ED46835

Q36235753-06686E32-13DF-4314-908B-1F04316F9481

Q36235753-0C292817-92BE-47D9-8166-FF8360E25185

Q36235753-0CD98C05-4C1E-47A1-A708-921993C080CC

Q36235753-220C96EF-D5F6-401F-94C1-E585748E7306

Q36235753-37D58FA1-1674-4FA9-98AB-12B6A4211A6D

Q36235753-3FFB7D2B-1324-4972-B504-2ED8DC0E6379

Q36235753-40D82A7B-EE84-4519-87B4-27184F6DDE69

P304

Q36235753-F3DF1A85-8D9B-4FB0-9BCB-605936F9738C

P31

Q36235753-CDD8792D-74E7-4A94-81D1-CB3FF5925846

P356

Q36235753-6004FF5C-03C4-40FE-927E-F1E31A81C242

P407

Q36235753-2A37349B-7725-48E7-9E22-030C364893E9

P433

Q36235753-8D118FE3-4770-4E7E-BDFC-09104ED58184

P478

Q36235753-80944ECF-F17B-44E9-A2B4-3771D396B0A8

P577

Q36235753-B5530040-1D47-4118-BC60-F8D02D89153E

P5875

Q36235753-4FFEB1DD-28F0-4C8C-8E65-2FBA2A5F42AF

P698

Q36235753-64258827-9AA1-4A32-B745-786E496EA4F6

P932

Q36235753-01F008B6-6B48-41FA-B90D-D0891D61E718

P356

P1433

Journal of Cell Biology

P1476

Non-muscle alpha-dystroglycan is involved in epithelial development.

@en

P2093

Campbell KP

http://www.w3.org/2001/XMLSchema#string

Durbeej M

http://www.w3.org/2001/XMLSchema#string

Ekblom P

http://www.w3.org/2001/XMLSchema#string

Ibraghimov-Beskrovnaya O

http://www.w3.org/2001/XMLSchema#string

Larsson E

http://www.w3.org/2001/XMLSchema#string

Roberds SL

http://www.w3.org/2001/XMLSchema#string

P2860

Human laminin M chain (merosin): complete primary structure, chromosomal assignment, and expression of the M and A chain in human fetal tissues

Integrin recognition of different cell-binding fragments of laminin (P1, E3, E8) and evidence that alpha 6 beta 1 but not alpha 6 beta 4 functions as a major receptor for fragment E8

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

Integrins: versatility, modulation, and signaling in cell adhesion

Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor

Human dystroglycan: skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization

Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix

Membrane organization of the dystrophin-glycoprotein complex

Dystrophin: the protein product of the Duchenne muscular dystrophy locus

Laminin, a multidomain protein. The A chain has a unique globular domain and homology with the basement membrane proteoglycan and the laminin B chains.

P304

79-91

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1083/JCB.130.1.79

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

130

http://www.w3.org/2001/XMLSchema#string

P577

1995-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277456402

http://www.w3.org/2001/XMLSchema#string

P698

7790379

http://www.w3.org/2001/XMLSchema#string

P932

2120507

http://www.w3.org/2001/XMLSchema#string